Cargando…
2512. A Decade in Review: An Analysis of the Qualified Infectious Disease Product (QIDP) Designation
BACKGROUND: The development of new antibiotics is a critical public health need, as antibiotic-resistant infections are responsible for tens of thousands of deaths each year in the U.S. In response, the QIDP (Qualified Infectious Disease Product) designation was established by the FDA under the Gene...
Autores principales: | Atillasoy, Cem, Elmansy, Lina, Gourlias, Panagiotis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677251/ http://dx.doi.org/10.1093/ofid/ofad500.2130 |
Ejemplares similares
-
1235. On the Edge of Tomorrow: Expedited Regulatory Pathways for Anti-Infective Therapies
por: Atillasoy, Cem, et al.
Publicado: (2020) -
2512. Decreasing Adherence to Antiretroviral Therapy over 4 Years of Follow-up in a Commercially-Insured Population of Patients with HIV
por: Priest, Julie, et al.
Publicado: (2019) -
2512. The Trend in the Incidence of Herpes Zoster and Effect of Immune Status on Severity and Healthcare Utilization: Population-Based Study of Korea, 2003–2015
por: Choi, Jae-Ki, et al.
Publicado: (2018) -
PB2512: SAFETY OF CRIZANLIZUMAB IN PATIENTS WITH SICKLE CELL DISEASE: INTEGRATED POST-MARKETING SURVEILLANCE ANALYSIS
por: Abboud, Miguel, et al.
Publicado: (2023) -
High-quality permanent draft genome sequence of the Parapiptadenia rigida-nodulating Cupriavidus sp. strain UYPR2.512
por: De Meyer, Sofie E, et al.
Publicado: (2015)